203 related articles for article (PubMed ID: 22189356)
1. Role of MYH9 and APOL1 in African and non-African populations with lupus nephritis.
Lin CP; Adrianto I; Lessard CJ; Kelly JA; Kaufman KM; Guthridge JM; Freedman BI; Anaya JM; Alarcón-Riquelme ME; ; Pons-Estel BA; Martin J; Glenn S; Adler A; Bae SC; Park SY; Bang SY; Song YW; Boackle SA; Brown EE; Edberg JC; Alarcón GS; Petri MA; Criswell LA; Ramsey-Goldman R; Reveille JD; Vila LM; Gilkeson GS; Kamen DL; Ziegler J; Jacob CO; Rasmussen A; James JA; Kimberly RP; Merrill JT; Niewold TB; Scofield RH; Stevens AM; Tsao BP; Vyse TJ; Langefeld CD; Moser KL; Harley JB; Gaffney PM; Montgomery CG
Genes Immun; 2012 Apr; 13(3):232-8. PubMed ID: 22189356
[TBL] [Abstract][Full Text] [Related]
2. Re-Sequencing of the APOL1-APOL4 and MYH9 Gene Regions in African Americans Does Not Identify Additional Risks for CKD Progression.
Hawkins GA; Friedman DJ; Lu L; McWilliams DR; Chou JW; Sajuthi S; Divers J; Parekh RS; Li M; Genovese G; Pollack MR; Hicks PJ; Bowden DW; Ma L; Freedman BI; Langefeld CD
Am J Nephrol; 2015; 42(2):99-106. PubMed ID: 26343748
[TBL] [Abstract][Full Text] [Related]
3. MYH9 and APOL1 gene polymorphisms and the risk of CKD in patients with lupus nephritis from an admixture population.
Colares VS; Titan SM; Pereira Ada C; Malafronte P; Cardena MM; Santos S; Santos PC; Fridman C; Barros RT; Woronik V
PLoS One; 2014; 9(3):e87716. PubMed ID: 24658608
[TBL] [Abstract][Full Text] [Related]
4. End-stage renal disease in African Americans with lupus nephritis is associated with APOL1.
Freedman BI; Langefeld CD; Andringa KK; Croker JA; Williams AH; Garner NE; Birmingham DJ; Hebert LA; Hicks PJ; Segal MS; Edberg JC; Brown EE; Alarcón GS; Costenbader KH; Comeau ME; Criswell LA; Harley JB; James JA; Kamen DL; Lim SS; Merrill JT; Sivils KL; Niewold TB; Patel NM; Petri M; Ramsey-Goldman R; Reveille JD; Salmon JE; Tsao BP; Gibson KL; Byers JR; Vinnikova AK; Lea JP; Julian BA; Kimberly RP;
Arthritis Rheumatol; 2014 Feb; 66(2):390-6. PubMed ID: 24504811
[TBL] [Abstract][Full Text] [Related]
5. The non-muscle Myosin heavy chain 9 gene (MYH9) is not associated with lupus nephritis in African Americans.
Freedman BI; Edberg JC; Comeau ME; Murea M; Bowden DW; Divers J; Alarcón GS; Brown EE; McGwin G; Kopp JB; Winkler CA; Nelson GW; Illei G; Petri M; Ramsey-Goldman R; Reveille JD; Vilá LM; Langefeld CD; Kimberly RP;
Am J Nephrol; 2010; 32(1):66-72. PubMed ID: 20523037
[TBL] [Abstract][Full Text] [Related]
6. Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene.
Tzur S; Rosset S; Shemer R; Yudkovsky G; Selig S; Tarekegn A; Bekele E; Bradman N; Wasser WG; Behar DM; Skorecki K
Hum Genet; 2010 Sep; 128(3):345-50. PubMed ID: 20635188
[TBL] [Abstract][Full Text] [Related]
7. The apolipoprotein L1 (APOL1) gene and nondiabetic nephropathy in African Americans.
Freedman BI; Kopp JB; Langefeld CD; Genovese G; Friedman DJ; Nelson GW; Winkler CA; Bowden DW; Pollak MR
J Am Soc Nephrol; 2010 Sep; 21(9):1422-6. PubMed ID: 20688934
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of MYH9 and APOL1 risk variants on FRMD3 Association with Diabetic ESRD in African Americans.
Freedman BI; Langefeld CD; Lu L; Divers J; Comeau ME; Kopp JB; Winkler CA; Nelson GW; Johnson RC; Palmer ND; Hicks PJ; Bostrom MA; Cooke JN; McDonough CW; Bowden DW
PLoS Genet; 2011 Jun; 7(6):e1002150. PubMed ID: 21698141
[TBL] [Abstract][Full Text] [Related]
9. A risk allele for focal segmental glomerulosclerosis in African Americans is located within a region containing APOL1 and MYH9.
Genovese G; Tonna SJ; Knob AU; Appel GB; Katz A; Bernhardy AJ; Needham AW; Lazarus R; Pollak MR
Kidney Int; 2010 Oct; 78(7):698-704. PubMed ID: 20668430
[TBL] [Abstract][Full Text] [Related]
10. Sickle cell trait is not independently associated with susceptibility to end-stage renal disease in African Americans.
Hicks PJ; Langefeld CD; Lu L; Bleyer AJ; Divers J; Nachman PH; Derebail VK; Bowden DW; Freedman BI
Kidney Int; 2011 Dec; 80(12):1339-43. PubMed ID: 21849968
[TBL] [Abstract][Full Text] [Related]
11. APOL1 variants increase risk for FSGS and HIVAN but not IgA nephropathy.
Papeta N; Kiryluk K; Patel A; Sterken R; Kacak N; Snyder HJ; Imus PH; Mhatre AN; Lawani AK; Julian BA; Wyatt RJ; Novak J; Wyatt CM; Ross MJ; Winston JA; Klotman ME; Cohen DJ; Appel GB; D'Agati VD; Klotman PE; Gharavi AG
J Am Soc Nephrol; 2011 Nov; 22(11):1991-6. PubMed ID: 21997397
[TBL] [Abstract][Full Text] [Related]
12. MYH9 and APOL1 are both associated with sickle cell disease nephropathy.
Ashley-Koch AE; Okocha EC; Garrett ME; Soldano K; De Castro LM; Jonassaint JC; Orringer EP; Eckman JR; Telen MJ
Br J Haematol; 2011 Nov; 155(3):386-94. PubMed ID: 21910715
[TBL] [Abstract][Full Text] [Related]
13. Genetic variation in APOL1 and MYH9 genes is associated with chronic kidney disease among Nigerians.
Tayo BO; Kramer H; Salako BL; Gottesman O; McKenzie CA; Ogunniyi A; Bottinger EP; Cooper RS
Int Urol Nephrol; 2013 Apr; 45(2):485-94. PubMed ID: 22956460
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein L1 gene variants associate with hypertension-attributed nephropathy and the rate of kidney function decline in African Americans.
Lipkowitz MS; Freedman BI; Langefeld CD; Comeau ME; Bowden DW; Kao WH; Astor BC; Bottinger EP; Iyengar SK; Klotman PE; Freedman RG; Zhang W; Parekh RS; Choi MJ; Nelson GW; Winkler CA; Kopp JB;
Kidney Int; 2013 Jan; 83(1):114-20. PubMed ID: 22832513
[TBL] [Abstract][Full Text] [Related]
15. APOL1 and nephropathy progression in populations of African ancestry.
Freedman BI
Semin Nephrol; 2013 Sep; 33(5):425-32. PubMed ID: 24119848
[TBL] [Abstract][Full Text] [Related]
16. Association of trypanolytic ApoL1 variants with kidney disease in African Americans.
Genovese G; Friedman DJ; Ross MD; Lecordier L; Uzureau P; Freedman BI; Bowden DW; Langefeld CD; Oleksyk TK; Uscinski Knob AL; Bernhardy AJ; Hicks PJ; Nelson GW; Vanhollebeke B; Winkler CA; Kopp JB; Pays E; Pollak MR
Science; 2010 Aug; 329(5993):841-5. PubMed ID: 20647424
[TBL] [Abstract][Full Text] [Related]
17. Collapsing glomerulopathy associated lupus in a black female with homozygous APOL1 mutation.
Kofman T; Narjoz C; Raimbourg Q; Loriot MA; Karras A; Roland M; Hill G; Jacquot C; Nochy D; Thervet E
Lupus; 2012 Nov; 21(13):1459-62. PubMed ID: 22952321
[TBL] [Abstract][Full Text] [Related]
18. Keloids and non-diabetic kidney disease: similarities and the APOL1-MYH9 haplotype as a possible genetic link.
Keeling BH; Taylor BR
Med Hypotheses; 2013 Nov; 81(5):908-10. PubMed ID: 24011553
[TBL] [Abstract][Full Text] [Related]
19. Target organ damage in African American hypertension: role of APOL1.
Freedman BI; Murea M
Curr Hypertens Rep; 2012 Feb; 14(1):21-8. PubMed ID: 22068337
[TBL] [Abstract][Full Text] [Related]
20. Epistatic role of the MYH9/APOL1 region on familial hematuria genes.
Voskarides K; Demosthenous P; Papazachariou L; Arsali M; Athanasiou Y; Zavros M; Stylianou K; Xydakis D; Daphnis E; Gale DP; Maxwell PH; Elia A; Pattaro C; Pierides A; Deltas C
PLoS One; 2013; 8(3):e57925. PubMed ID: 23516419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
